A Study of Daridorexant in Chinese Patients With Insomnia Disorder
Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the efficacy and safety of 50 mg daridorexant
in adult and elderly chinese patients with insomnia disorder.
Efficacy will be evaluated on objective and subjective sleep parameters .